Seasoned investor and operator focused on technology and consumer growth equity, bringing hands-on scaling experience and deal execution across venture and private markets. Adam Weisner is a former founder and investment professional who combines financial analysis, capital-raising and board-level governance to drive revenue expansion and operational improvements. He specializes in growth-stage value creation, strategic M&A and structuring follow-on financings for founder-led businesses.
Seasoned investor and operator focused on technology and consumer growth equity, bringing hands-on scaling experience and deal execution across venture and private markets. Adam Weisner is a former founder and investment professional who combines financial analysis, capital-raising and board-level governance to drive revenue expansion and operational improvements. He specializes in growth-stage value creation, strategic M&A and structuring follow-on financings for founder-led businesses.
Focuses on growth equity in technology and consumer businesses, prioritizing founder-led companies with clear unit economics and scalable go-to-market models. Emphasizes active board-level partnership, operational roadmaps and follow-on financing cadence to accelerate revenue expansion and margin improvement. Employs rigorous financial underwriting, milestone-based capital deployment and a multi-stage exit time horizon of three to seven years. Risk is managed via stage-appropriate covenants, concentrated but diversified sector exposure, and a bias toward companies where hands-on operating experience drives measurable value creation.
Focuses on growth equity in technology and consumer businesses, prioritizing founder-led companies with clear unit economics and scalable go-to-market models. Emphasizes active board-level partnership, operational roadmaps and follow-on financing cadence to accelerate revenue expansion and margin improvement. Employs rigorous financial underwriting, milestone-based capital deployment and a multi-stage exit time horizon of three to seven years. Risk is managed via stage-appropriate covenants, concentrated but diversified sector exposure, and a bias toward companies where hands-on operating experience drives measurable value creation.
| Trades 506 | Longs Won 313/506 61% | Profit Factor 1.77 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $3.11M |
| Average Win $690,672.94 | Best Trade (Oct 15) $23.44M | Sharpe Ratio -1.14 |
| Average Loss -$631,181.89 | Worst Trade (Mar 31) -$45.23M | Z-Score 0.82 (58.97%) |
| Commissions $0 | Avg. Trade Length 6m 2w 6d | Expectancy $187,186.84 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.36% |
| Consecutive Losing Trades | 2,193 | 1,974 | 1,754 | 1,535 | 1,316 | 1,096 | 877 | 658 | 439 | 219 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 24,299 | $6.27M | $8.32M | - | $2.06M | 32.82% | -0.146% |
ABBV AbbVie Inc. | 27,808 | $6.34M | $7.92M | - | $1.58M | 25.01% | +1.079% |
ABT Abbott Laboratories | 43,409 | $5.3M | $4.55M | - | -$750,809.26 | -14.18% | +1.7% |
ADP Automatic Data Processing Inc. | 21,073 | $5.19M | $6.07M | - | $878,330.32 | 16.92% | +2.726% |
AMGN Amgen Inc. | 17,242 | $5.67M | $7.57M | - | $1.89M | 33.38% | +3.02% |
AMT American Tower Corporation | 28,891 | $4.99M | $5.24M | - | $250,629.9 | 5.03% | +1.034% |
AMZN Amazon.com Inc | 15,092 | $3.44M | $3.84M | - | $404,245.33 | 11.76% | +0.179% |
AVGO Broadcom Inc. | 17,865 | $6.18M | $6.09M | - | -$89,856 | -1.45% | -1.497% |
AZN AstraZeneca PLC American Depositary Shares | 33,173 | $6.54M | $5.55M | - | -$991,208.78 | -15.15% | +3.277% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 2,541 | $232,196.65 | $232,590.43 | - | $393.78 | 0.17% | +0.022% |
BIV Vanguard Intermediate-Term Bond ETF (likely mapping for ticker 0V1L) | 496,303 | $38.61M | $36.51M | - | -$2.1M | -5.43% | +0.671% |
BND Vanguard Total Bond Market Index Fund | 422,886 | $31.07M | $29.95M | - | -$1.12M | -3.59% | +0.614% |
| BPRE BPRE | 219,883 | $3.3M | $3.3M | - | - | - | 0.0 |
BRK-B Berkshire Hathaway Inc. | 10,458 | $5.25M | $5.52M | - | $279,074.68 | 5.32% | +0.361% |
C Citigroup Inc. | 54,166 | $6.31M | $6.66M | - | $349,010.14 | 5.53% | +0.601% |
CION Cion Investment Corporation | 143,122 | $1.38M | $993,982.29 | - | -$390,009.77 | -28.18% | +3.348% |
COP ConocoPhillips | 79,821 | $8.7M | $11.32M | - | $2.62M | 30.12% | -0.372% |
CRM Salesforce Inc | 17,292 | $3.23M | $4.24M | - | $1.01M | 31.27% | +3.85% |
CVX Chevron Corporation | 33,020 | $5.09M | $7.23M | - | $2.15M | 42.2% | -1.371% |
CW Curtiss-Wright Corporation | 400 | $220,508 | $199,056 | - | -$21,452 | -9.73% | -0.567% |